A- A A+

Chun-Ying Wu (吳俊穎)

Chun-Ying Wu(吳俊穎)

簡介

學歷
  1. 國立台灣大學醫學士、醫學博士
  2. 美國哈佛大學法學碩士、公共衛生碩士
  3. 私立東海大學法學士
經歷 現職:
  1. - 迄今 臺北榮民總醫院 醫學研究部轉譯研究科 主任
  2. - 迄今 臺北榮民總醫院 卓越癌症研究中心 主任
  3. - 迄今 臺北榮民總醫院 胃腸肝膽科 兼任主治醫師
  4. - 迄今 國立陽明大學 生物醫學資訊研究所 所長
  5. - 迄今 國家衛生研究院 癌症研究所 合聘研究員
  6. - 迄今 台灣微菌聯盟 理事長
經歷:
  1. - 2016-2018年台灣醫事法律學會 理事長
  2. - 2018年台灣醫療典範獎
  3. - 2016年生策會國家新創獎
  4. - 2015年 科技部傑出研究獎
  5. - 2015年 亞太消化系醫學會新興領袖獎
醫療專長
  1. 胃癌、肝癌、大腸癌、克隆式疾病、潰瘍性腸炎
  2. B型肝炎、C型肝炎、肝硬化、肝炎抗病毒藥物治療
  3. 逆流性食道炎、消化性潰瘍、幽門螺旋桿菌、腸道微菌
證照
  1. 內科專科醫師
  2. 消化內科專科醫師
  3. 消化系內視鏡專科醫師
  4. 肝癌專科醫師
語言專長
  1. 國語、台語、英文

著作

醫學著作:發表SCI 文章近 140篇, 消化系癌症、肝炎、及幽門螺旋桿菌研究為研究主軸. 以第一作者或通訊作者發表SCI impact factor 超過10分原始著作18篇

  1. Wu CY*, Chen YJ, Ho HJ, Hsu YC, Kuo KN, Wu MS, Lin JT. Association between nucleoside analogues and risk of hepatitis B virus-related hepatocellular carcinoma following liver resection. JAMA 2012 Nov 12, 308(18): 1906-13.
  2. Wu CY*, Wu MS, Kuo KN, Chen YJ, Wang CB, Lin JT. Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients. J Clin Oncol 2010 Jun; 28(18): 2952-7.
  3. Lee TY, Hsu YC, Tseng HC, Yu SH, Lin JT, Wu MS, Wu CY*. Association of daily aspirin therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B. JAMA Intern Med 2019 Mar 18, Epub ahead of print.
  4. Yeo YH, Ho HJ, Yang HI…, Wu CY*, Nguyen MH. The HBsAg seroclearance rate and predictors in adults with chronic hepatitis B: a systematic review and meta-analysis. Gastroenterology 2019 Feb; 156(3): 635-46.
  5. Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang SY, Wu C, Wu JC. Association of nucleos(t)ide analogues therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Gastroenterology 2014 Jul; 147(1): 143-51.e5.
  6. Wu CY*, Chan FK, Wu MS, Kuo KN, Wang CB, Tsao CR, Lin JT. Histamine-2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel. Gastroenterology 2010 Oct; 139(4): 1165-71.
  7. Wu CY, Kuo KN, Wu MS, Chen YJ, Wang CB, Lin JT. Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 2009 Nov; 137(5):1641-8.
  8. Yeo YH, Shiu SI, Ho HJ, Zou B, Lin JT, Wu MS, Liou JM, Wu CY*. First-line Helicobacter pylori eradication therapies in countries with high and low clarithromycin resistance: a systematic review and network meta-analysis. Gut 2018 Jan; 67(1): 20-7.
  9. Wu CY*, Hsu YC, Ho HJ, Chen YJ, Lee TY, Lin JT. Association between ultrasonography screening and mortality in patients with hepatocellular carcinoma: a nationwide cohort study. Gut 2016 Apr; 65(4): 693-701.
  10. Hsu YC, Ho HJ, Huang YT, Wang HH, Wu MS, Lin JT, Wu CY*. Association between antiviral therapy and extrahepatic outcomes in patients with hepatitis C virus infection. Gut 2015 Mar; 64(3): 495-503.
  11. Chen HP, Shieh JJ, Chang CC, Chen TT, Lin JT, Wu MS, Lin JH, Wu CY*. Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies. Gut 2013 Apr; 62(4): 606-15.
  12. Wu CY, Wu MS, Kuo KN, Wang CB, Chen YJ, Lin JT. Long term peptic ulcer rebleeding risk estimation in patients undergoing haemodialysis: a 10-year nationwide cohort study. Gut 2011 Aug; 60(8): 1038-42.
  13. Wu CY, Wu MS, Chiang EP, Wu CC, Chen YJ, Chen CJ, Chi NH, Chen GH, Lin JT. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival. Gut 2007 Jun;56(6):782-9.
  14. Hsu YC, Yip TCF, Ho HJ, Wong VWS, Huang YT, El-Serag HB, Lee TY, Wu MS, Lin JT, Wong GLH, Wu CY*. Predicting hepatocellular carcinoma with population-wide data in previously untreated Asians on antivirals for chronic hepatitis B. J Hepatol 2018 Aug; 69(2): 278-85.
  15. Lee TY, Lin JT, Zeng YS, Chen YJ, Wu MS, Wu CY*. Association between nucleos(t)ide analogues and tumor recurrence in hepatitis B virus-related hepatocellular carcinoma following radiofrequency ablation. Hepatology 2016 May; 63(5): 1517-27.
  16. Hsu YC, Lin JT, Ho HJ, Kao YH, Huang YT, Hsiao NW, Wu MS, Liu YY, Wu CY*. Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients. Hepatology 2014 Apr; 59(4):1293-302.
  17. Hsu YC, Ho HJ, Wu MS, Lin JT, Wu CY*. Postoperative peg-interferon plus ribavirin associated with reduced recurrence of hepatitis C virus-related hepatocellular carcinoma. Hepatology 2013 Jul; 58(1): 150-7.
  18. Hsu YC, Lin JT, Chen TT, Wu MS, Wu CY*. Long-term risk of recurrent peptic ulcer bleeding in patients with liver cirrhosis: a 10-year nationwide cohort study. Hepatology 2012 Aug 56(2): 698-705.

 

  •  

1.    吳俊穎:現行醫療鑑定制度介紹及改革建議 (元照出版社,2014年12月出版)。

2.    吳俊穎、陳榮基、楊增暐、翁慧卿、賴惠蓁:實證法學:醫療糾紛的全國性實證研究 (元照出版社,2014年8月出版)。

3.    吳俊穎、陳榮基、楊增暐、賴惠蓁、吳佳勳:清官難斷醫務事?醫療過失責任與醫療糾紛鑑定 (元照出版社,2013年7月二版)。

4.    吳俊穎、賴惠蓁、陳榮基:法官,我說明夠了嗎?醫師說明義務法院判決評析 (橘井出版社,2010年7月出版)。